Treehouse Eyes, The First and Only Health Care Business Treating Myopia in Children, Sees 30 Percent Patient Increase During Pandemic

Treehouse Eyes, The First and Only Health Care Business Treating Myopia in Children, Sees 30 Percent Patient Increase During Pandemic

Significant Business Growth in Just Five Years Underscores Greater Need for Myopia Management


Boulder, CO. (Aug. 27, 2021) — Treehouse Eyes, the largest myopia management provider in the country, has observed a 30 percent increase in the number of myopic children being treated since the pandemic began. Myopia, or nearsightedness, is a disease that usually starts in school-aged children and causes the eye to grow too long, resulting in blurry distance vision and an increased lifetime risk of serious eye diseases.


New research published in the Journal of the American Medical Association (JAMA) found that home confinement during the pandemic has created a significant increase in myopia for children aged 6 to 8 years, with the prevalence of myopia increasing 1.4 to 3 times in 2020 compared with the previous 5 years. The COVID-19 pandemic has exacerbated myopia’s risk factors, including increased exposure to digital devices and limited access to outdoor time.  The mar


As the leading myopia management provider in the country, Treehouse Eyes has seen significant growth in both size and scale since it was founded in 2016. In just five years the company has grown from:


    Zero to 50 locations, with 60 locations expected by the end of 2021

  Two states to 18 states

  1 on-staff doctor to 75 in-company and licensed medical professionals

  Same-store revenue growth of 40 percent and total company revenue growth of over 100 percent in 2021 vs. 2020

  350 percent growth in web traffic to the Treehouse Eyes website from 2020 to 2021


The market opportunity for myopia management is incredibly strong, with companies like CooperVision and Johnson & Johnson making significant investments in the marketplace to develop myopia management products – something that Treehouse Eyes has been committed to since its inception.


“Today, the industry represents a $55B total global addressable market and by 2050, it is anticipated to be more than $200B,” said Matt Oerding, CEO and co-founder of Treehouse Eyes. “This is a larger addressable market than braces and we are proud Treehouse Eyes is at the forefront.”


Treehouse Eyes’ patent-pending protocol, the Treehouse Vision System, has been shown to decrease the progression of myopia in kids and teens by up to 78 percent. By expanding its network of locations, this system will be available for more doctors to use and limit the progression of childhood myopia in their communities. Especially surrounding the pandemic, Treehouse Eyes is strongly urging parents to consider the importance of their children’s eye exams this year and start myopia treatment if needed.


For more information and to schedule a free myopia consultation, please visit the Treehouse Eyes website. For media inquiries, contact Jason Feldman at [email protected].


About Treehouse Eyes

The mission of Treehouse Eyes is to give children a better vision for life. As the first and only health care business dedicated exclusively to treating myopic children, Treehouse Eyes’ doctors have helped thousands of children have better vision and reduce their risks of serious eye diseases associated with myopia. Treehouse Eyes providers have the latest equipment and clinical training to diagnose myopia and recommend a customized treatment plan for each child to get the best results. Treehouse Eyes currently has 50 locations in 18 states, making Treehouse Eyes the largest myopia management provider in the country.